Stacy Remiszewski - Concepedia

Author

Stacy Remiszewski

Also Known As

S Remiszewski, S. REMISZEWSKI, S. Remiszewski, S. W. REMISZEWSKI, S.W. Remiszewski, Stacy Remiszewski, Stacy W Remiszewski, Stacy W. Remiszewski

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)AIL Research (United States)Pennsylvania State University Novartis (Switzerland)Harvard University

About

Stacy Remiszewski is an author at Novartis (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	21	1.8K
2	Biochemistry	10	10	839
3	Natural Sciences	9	9	784
4	Biomolecular Engineering	8	8	337
5	Engineering	4	4	193

Stacy Remiszewski

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Ming Liu, Matthew Bryant, Jianping Chen, PubMed Sch 66336Chemoprevention StrategyFarnesyl Protein TransferaseOncogenic AgentMedicine	1998	309
Psammaplins from the Sponge <i>Pseudoceratina </i><i>p</i><i>urpurea:</i> Inhibition of Both Histone Deacetylase and DNA Methyltransferase Ivette C. Piña, Jeffrey T. Gautschi, Gui-Yang-Sheng Wang, The Journal of Organic Chemistry Epigenetic ChangeMolecular BiologyDna MethyltransferaseChemical BiologyEpigenetics	2003	307
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma Laurence Catley, Ellen Weisberg, Yu-Tzu Tai, Blood	2003	219
Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824 Peter Atadja, Lin Gao, Paul Kwon, Cancer Research Histone ModificationsHistone Deacetylase InhibitorTumor CellsCancer BiologyTumor Biology	2004	134
<i>N</i>-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity: Discovery of (2<i>E</i>)-<i>N</i>-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1<i>H</i>-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824) Stacy Remiszewski, Lidia Sambucetti, Kenneth W. Bair, Journal of Medicinal Chemistry PathologyPharmacotherapyPharmaceutical ChemistryTumor BiologyMedicinal Chemistry	2003	129
Ras oncoprotein inhibitors: The discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex Arthur G. Taveras, Stacy Remiszewski, Ronald J. Doll, Bioorganic & Medicinal Chemistry Molecular DockingDrug TargetBiochemistryDrug-protein ComplexMedicine	1997	121
Inhibitors of Human Histone Deacetylase: Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates Stacy Remiszewski, Lidia Sambucetti, Peter Atadja, Journal of Medicinal Chemistry	2002	114
(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5<i>H</i>-benzo[5,6]cyclohepta[1,2-<i>b</i>]- pyridin-11(<i>R</i>)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamide (SCH-66336): A Very Potent Farnesyl Protein Transferase Inhibitor as a Novel Antitumor Agent F. George Njoroge, Arthur G. Taveras, Joseph Kelly, Journal of Medicinal Chemistry Bioorganic ChemistryPharmacotherapyPharmaceutical ChemistryTricyclic Ring SystemBromine Atom	1998	97
Tricyclic Farnesyl Protein Transferase Inhibitors: Crystallographic and Calorimetric Studies of Structure−Activity Relationships Corey L. Strickland, Patricia C Weber, William T. Windsor, Journal of Medicinal Chemistry Amide CarbonylMolecular BiologyComplex FormationChemical BiologyPharmaceutical Chemistry	1999	88
Small-molecule inhibitors that disrupt the MTDH–SND1 complex suppress breast cancer progression and metastasis Minhong Shen, Yong Wei, Hahn Kim, Nature Cancer Breast OncologyMedicineSmall-molecule InhibitorsBreast CancerAnti-cancer Agent	2021	69

Page 1